These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 34286438)

  • 1. CXCL3 Signaling in the Tumor Microenvironment.
    Reyes N; Figueroa S; Tiwari R; Geliebter J
    Adv Exp Med Biol; 2021; 1302():15-24. PubMed ID: 34286438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL3: A key player in tumor microenvironment and inflammatory diseases.
    Bao Y; Tong C; Xiong X
    Life Sci; 2024 Jul; 348():122691. PubMed ID: 38714265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer.
    Song N; Cui K; Zeng L; Li M; Fan Y; Shi P; Wang Z; Su W; Wang H
    Eur J Pharmacol; 2024 Mar; 967():176357. PubMed ID: 38309677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines.
    Sun X; Chen Q; Zhang L; Chen J; Zhang X
    Math Biosci Eng; 2021 Jul; 18(5):6262-6287. PubMed ID: 34517533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CXC chemokines and their receptors in cancer.
    Vandercappellen J; Van Damme J; Struyf S
    Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ELR+ CXC chemokines in human milk.
    Maheshwari A; Christensen RD; Calhoun DA
    Cytokine; 2003 Nov; 24(3):91-102. PubMed ID: 14581003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and clinical significance of CXC chemokines in the glioblastoma microenvironment.
    Li C; Deng H; Zhou Y; Ye Y; Zhao S; Liang S; Cai S; Lin J; Tang Y; Wu Y
    Life Sci; 2020 Nov; 261():118486. PubMed ID: 32976881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis.
    Addison CL; Arenberg DA; Morris SB; Xue YY; Burdick MD; Mulligan MS; Iannettoni MD; Strieter RM
    Hum Gene Ther; 2000 Jan; 11(2):247-61. PubMed ID: 10680839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of prognostic value and immune infiltration of CXC chemokines in pancreatic cancer.
    Jing Y; Wang F; Zhang K; Chen Z
    BMC Med Genomics; 2022 Apr; 15(1):96. PubMed ID: 35468838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor microenvironment signaling and therapeutics in cancer progression.
    Goenka A; Khan F; Verma B; Sinha P; Dmello CC; Jogalekar MP; Gangadaran P; Ahn BC
    Cancer Commun (Lond); 2023 May; 43(5):525-561. PubMed ID: 37005490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
    Bièche I; Chavey C; Andrieu C; Busson M; Vacher S; Le Corre L; Guinebretière JM; Burlinchon S; Lidereau R; Lazennec G
    Endocr Relat Cancer; 2007 Dec; 14(4):1039-52. PubMed ID: 18045955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis.
    Wu C; Ma C; Yuan J; Zhou P
    Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix.
    Engl T; Relja B; Blumenberg C; Müller I; Ringel EM; Beecken WD; Jonas D; Blaheta RA
    Life Sci; 2006 Mar; 78(16):1784-93. PubMed ID: 16263140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment.
    Zeng Q; Sun S; Li Y; Li X; Li Z; Liang H
    Front Oncol; 2019; 9():1555. PubMed ID: 32117786
    [No Abstract]   [Full Text] [Related]  

  • 15. The Inflammatory CXC Chemokines, GROα
    Cao Y; Huang H; Wang Z; Zhang G
    Immunol Invest; 2017 May; 46(4):361-374. PubMed ID: 28375674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic values of C‑X‑C motif chemokine ligand 3 in patients with colon cancer.
    Ruan GT; Gong YZ; Liao XW; Wang S; Huang W; Wang XK; Zhu GZ; Liao C; Gao F
    Oncol Rep; 2019 Nov; 42(5):1996-2008. PubMed ID: 31545503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.
    Korbecki J; Kojder K; Kapczuk P; Kupnicka P; Gawrońska-Szklarz B; Gutowska I; Chlubek D; Baranowska-Bosiacka I
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.
    Bizzarri C; Beccari AR; Bertini R; Cavicchia MR; Giorgini S; Allegretti M
    Pharmacol Ther; 2006 Oct; 112(1):139-49. PubMed ID: 16720046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives.
    Huang X; Hao J; Tan YQ; Zhu T; Pandey V; Lobie PE
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting.
    Lee HJ; Song IC; Yun HJ; Jo DY; Kim S
    World J Gastroenterol; 2014 Feb; 20(7):1681-93. PubMed ID: 24587647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.